{"id":6115,"date":"2024-10-24T16:03:25","date_gmt":"2024-10-24T16:03:25","guid":{"rendered":"https:\/\/ramib.org\/oficial\/?p=6115"},"modified":"2024-11-14T16:23:43","modified_gmt":"2024-11-14T16:23:43","slug":"6115","status":"publish","type":"post","link":"https:\/\/ramib.org\/oficial\/index.php\/2024\/10\/24\/6115\/","title":{"rendered":"05\/11\/2024: La Immunoter\u00e0pia: un canvi de paradigma en el tractament del C\u00e0ncer?"},"content":{"rendered":"\n<p>Dimarts passat, 5 de novembre de 2024, la seu de la Reial Acad\u00e8mia de Medicina dels Illes Balears va acollir la sessi\u00f3 cient\u00edfica &#8220;La Immunoter\u00e0pia: un canvi de paradigma en el tractament del C\u00e0ncer?\u201d.<\/p>\n\n\n\n<p>La sessi\u00f3 va ser duta a terme pel Dr. Pere Gascon, Professor titular de Medicina i Director del Laboratori d\u2019Oncologia Molecular i Traslacional de la Facultat de Biol\u00f2giques de la Universitat de Barcelona. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2.jpg\" alt=\"\" class=\"wp-image-6148\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon2-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Va obrir l&#8217;acte el president de la RAMIB, Excm. Sr. Joan Besalduch Vidal, donant la benvinguda a les autoritats, ponents i al p\u00fablic present i presentant al ponent i va exposar un breu resum del seu curr\u00edculum. <\/p>\n\n\n\n<p>El professor Gascon va exposar que als tractaments actuals del c\u00e0ncer, la incorporaci\u00f3 de la immunoter\u00e0pia s\u00b4ha fet gaireb\u00e9 generalitzada. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1.jpg\" alt=\"\" class=\"wp-image-6142\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-1-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Immunoter\u00e0pia \u00e9s utilitzar el sistema immunol\u00f2gic per atacar el tumor. Tot comen\u00e7a amb el descobriment dels \u201ccheck point inhibitors\u201d per la qual cosa els seus descobridors, l\u00b4americ\u00e0 Dr. Jim Allison i el japon\u00e8s Tasuku Honjo varen rebre el Premi Nobel de Medicina de l\u00b4any 2018. Els primers \u00e8xits cl\u00ednics varen passar amb el melanoma maligne i varen ser excel\u00b7lents. <\/p>\n\n\n\n<p>El ponent va seguir informant que tamb\u00e9 tenim els tractaments amb manipulaci\u00f3 dels limf\u00f2cits del propi malalt: limf\u00f2cits que infiltren el tumor, c\u00e8l\u00b7lules CART, els conjugats de anticossos monoclonals carregats de quimioter\u00e0pia que actuen com a cavalls de Troia a les c\u00e8l\u00b7lules canceroses. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-1024x683.jpg\" alt=\"\" class=\"wp-image-6150\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-1024x683.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-1536x1024.jpg 1536w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-2048x1365.jpg 2048w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-1068x712.jpg 1068w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-630x420.jpg 630w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon3-1920x1280.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Per tot aix\u00f2 la immunoter\u00e0pia porta molta esperan\u00e7a per tots els nostres malalts amb c\u00e0ncer i podem dir ja, que estem al principi d\u00b4una nova era. Cada vegada els tractaments de ter\u00e0pia dirigida, antidiana, o personalitzats aniran en augment i tractarem al malalt en funci\u00f3 de la gen\u00e8tica. <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4.jpg\" alt=\"\" class=\"wp-image-6152\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon4-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>En un futur es podr\u00e0 tractar igual una leuc\u00e8mia que un sarcoma perqu\u00e8 tenen les mateixes aberracions gen\u00e8tiques. La gen\u00e8tica \u00e9s cada vegada m\u00e9s important en la classificaci\u00f3 dels c\u00e0ncer. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5.jpg\" alt=\"\" class=\"wp-image-6144\" srcset=\"https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5.jpg 1024w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5-300x200.jpg 300w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5-768x512.jpg 768w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5-696x464.jpg 696w, https:\/\/ramib.org\/oficial\/wp-content\/uploads\/2024\/10\/gascon-5-630x420.jpg 630w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n\n<p>Una vegada finalitzada la pon\u00e8ncia es va obrir el torn obert de paraula habitual en el qual el p\u00fablic va poder plantejar diverses q\u00fcestions que van ser respostes pel ponent. <\/p>\n\n\n\n<p>En finalitzar el debat el president de la corporaci\u00f3 va tancar l&#8217;acte agraint al ponent la seva magn\u00edfica pon\u00e8ncia.<\/p>\n\n\n\n<p>Pot visualitzar la sessi\u00f3 cient\u00edfica en el canal de youtube de la corporaci\u00f3:<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"05\/11\/2024: La Immunoter\u00e0pia: un canvi de paradigma en el tractament del C\u00e0ncer?\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/vS1Daxk1T4Y?start=2225&#038;feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Dimarts passat, 5 de novembre de 2024, la seu de la Reial Acad\u00e8mia de Medicina dels Illes Balears va acollir la sessi\u00f3 cient\u00edfica &#8220;La Immunoter\u00e0pia: un canvi de paradigma en [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":6146,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[14,24,686,17],"tags":[218,266,280,1225,1223,232,1224,199,638,340],"_links":{"self":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/6115"}],"collection":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/comments?post=6115"}],"version-history":[{"count":5,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/6115\/revisions"}],"predecessor-version":[{"id":6159,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/posts\/6115\/revisions\/6159"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/media\/6146"}],"wp:attachment":[{"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/media?parent=6115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/categories?post=6115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ramib.org\/oficial\/index.php\/wp-json\/wp\/v2\/tags?post=6115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}